Paper
22 July 2019 Increase and homogenization of the endogenous production of protoporphyrin IX by photobiomodulation
Author Affiliations +
Abstract
Photodynamic therapy (PDT) and/or photodetection (PDD) based on protoporphyrin IX (PpIX) are used in many medical fields. However, the endogenous production of PpIX in the tissue after administration of its precursor, 5-aminolevulinic acid (ALA), is frequently insufficient and, in particular, inhomogeneous, leading to unsatisfactory treatment outcomes or false negatives. Photobiomodulation (PBM), which is based on the application of a sub-thermal dose of red or near infrared light (typically in the range of 600 – 900 nm), is known to modulate, among others, the cell metabolism, as demonstrated by an increased production of adenosine triphosphate and changes of the mitochondrial potential. Yet, the precise mechanism of PBM and, furthermore, the optimal irradiation conditions are to be determined. In the work reported here, we have studied the dependence of the endogenous PpIX production by U-87 glioma cells on various PBM irradiation protocols (wavelengths, irradiations, light doses). We have shown that PBM can increase, and even homogenize the endogenous production of PpIX in these cells. Therefore, combining PBM with PDT or PDD could lead to more potent and satisfying cancer treatments or detections outcomes, in particular in neurosurgery, dermatology, and urology.
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jaroslava Joniová, Emmanuel Gerelli, and Georges Wagnières "Increase and homogenization of the endogenous production of protoporphyrin IX by photobiomodulation", Proc. SPIE 11079, Medical Laser Applications and Laser-Tissue Interactions IX, 110790Q (22 July 2019); https://doi.org/10.1117/12.2527082
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Homogenization

Photodynamic therapy

Cancer

Oncology

Tissues

In vitro testing

Back to Top